Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Infect Dis ; 221(8): 1371-1378, 2020 03 28.
Artículo en Inglés | MEDLINE | ID: mdl-31267128

RESUMEN

BACKGROUND: Since 2000, the reported prevalence of tick-borne spotted fever rickettsiosis has increased considerably. We compared the level of antibody reactivity among healthy blood donors from 2 widely separated regions of the United States and evaluated the impact of antibody prevalence on public health surveillance in one of these regions. METHODS: Donor serum samples were evaluated by indirect immunofluorescence antibody assay to identify immunoglobulin G (IgG) antibodies reactive with Rickettsia rickettsii. The Georgia Department of Public Health (GDPH) analyzed characteristics of cases from 2016 surveillance data to evaluate the utility of laboratory surveillance for case assessment. RESULTS: Of the Georgia donors (n = 1493), 11.1% demonstrated antibody titers reactive with R. rickettsii at titers ≥64, whereas 6.3% of donors from Oregon and Washington (n = 1511) were seropositive. Most seropositive donors had a titer of 64; only 3.1% (n = 93) of all donors had titers ≥128. During 2016, GDPH interviewed 243 seropositive case patients; only 28% (n = 69) met inclusion criteria in the national case definition for spotted fever rickettsiosis. CONCLUSIONS: These findings suggest that a single IgG antibody titer is an unreliable measure of diagnosis and could inaccurately affect surveillance estimates that define magnitude and clinical characteristics of Rocky Mountain spotted fever and other spotted fever rickettsioses.


Asunto(s)
Anticuerpos Antibacterianos/sangre , Anticuerpos Antibacterianos/inmunología , Rickettsia rickettsii/inmunología , Fiebre Maculosa de las Montañas Rocosas/inmunología , Fiebre Maculosa de las Montañas Rocosas/microbiología , Rickettsiosis Exantemáticas/inmunología , Rickettsiosis Exantemáticas/microbiología , Adolescente , Adulto , Anciano , Animales , Vectores Arácnidos/microbiología , Donantes de Sangre , Femenino , Georgia , Humanos , Inmunoglobulina G/inmunología , Pruebas Inmunológicas/métodos , Masculino , Persona de Mediana Edad , Oregon , Infecciones por Rickettsia/inmunología , Infecciones por Rickettsia/microbiología , Estados Unidos , Washingtón , Adulto Joven
2.
J Nat Prod ; 75(9): 1632-6, 2012 Sep 28.
Artículo en Inglés | MEDLINE | ID: mdl-22928967

RESUMEN

Renal or kidney cancer accounts for about 3% of all cancer cases reported each year in the U.S. Molecular signatures that define the cancer, such as the loss of functional VHL, are found in both sporadic and familial cases of cancer. In clear cell renal cancer, the transcription factor HIF-2α has been shown to have a distinct role in tumorigenesis. Our laboratories developed a cell-based screen to identify modulators of HIF-2α. Screening of the NCI's Natural Product Extract Repository resulted in the identification of 10 sponge extracts, from which 12 compounds were isolated. The biological evaluation of these compounds will be discussed including evaluation of HIF-1α vs HIF-2α selectivity and the isolated compounds' effects on mRNA from several pathways regulated by HIF.


Asunto(s)
Factores de Transcripción con Motivo Hélice-Asa-Hélice Básico/antagonistas & inhibidores , Productos Biológicos/aislamiento & purificación , Productos Biológicos/farmacología , Poríferos/química , Animales , Factores de Transcripción con Motivo Hélice-Asa-Hélice Básico/genética , Productos Biológicos/química , Humanos , Neoplasias Renales/genética , Neoplasias Renales/metabolismo , Biología Marina , Estructura Molecular , ARN Mensajero/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA